Common use of Audit Committee Clause in Contracts

Audit Committee. The Board has validly appointed an audit committee whose composition satisfies the requirements of Rule 5605 of the Nasdaq Stock Market and the Board and/or the audit committee has adopted a charter that satisfies the requirements of Rule 5605 of the Nasdaq Stock Market. The audit committee has reviewed the adequacy of its charter within the past twelve months.

Appears in 11 contracts

Sources: Underwriting Agreement (Brickell Biotech, Inc.), Underwriting Agreement (Brickell Biotech, Inc.), Underwriting Agreement (Bionano Genomics, Inc)

Audit Committee. The Board Company’s board of directors has validly appointed an audit committee whose composition satisfies the applicable requirements of Nasdaq Marketplace Rule 5605 of the Nasdaq Stock Market 5605(c)(2) and the Board Company’s board of directors and/or the audit committee has adopted a charter that satisfies the requirements of Nasdaq Marketplace Rule 5605 of the Nasdaq Stock Market. The audit committee has reviewed the adequacy of its charter within the past twelve months5605(c)(1).

Appears in 3 contracts

Sources: Underwriting Agreement (OvaScience, Inc.), Underwriting Agreement (NPS Pharmaceuticals Inc), Underwriting Agreement (OvaScience, Inc.)

Audit Committee. The Company’s Board of Directors has validly appointed an audit committee whose composition satisfies the requirements of Rule 5605 5605(c)(2) of the Nasdaq Stock Market Listing Rules of NASDAQ (the “NASDAQ Listing Rules”) and the Company’s Board of Directors and/or the audit committee has adopted a charter that satisfies the requirements of Rule 5605 5605(c)(1) of the Nasdaq Stock MarketNASDAQ Listing Rules. The audit committee has reviewed the adequacy of its charter within the past twelve months.

Appears in 2 contracts

Sources: Underwriting Agreement (Endologix Inc /De/), Underwriting Agreement (Endologix Inc /De/)

Audit Committee. The Board Company’s board of directors has validly appointed an audit committee whose composition satisfies the requirements of Rule 5605 of the Nasdaq Stock Market NASDAQ and the Board board of directors and/or the audit committee has adopted a charter that satisfies the requirements of Rule 5605 of the Nasdaq Stock Market. The audit committee has reviewed the adequacy of its charter within the past twelve monthsNASDAQ.

Appears in 2 contracts

Sources: Purchase Agreement (Akoustis Technologies, Inc.), Purchase Agreement (Northwest Biotherapeutics Inc)

Audit Committee. The Board Company’s board of directors has validly appointed an audit committee whose composition satisfies the applicable requirements of Rule 5605 of the Nasdaq Stock NASDAQ Global Market and the Board Company’s board of directors and/or the audit committee has adopted a charter that satisfies the applicable requirements of Rule 5605 of the Nasdaq Stock NASDAQ Global Market. The audit committee has reviewed the adequacy of its charter within the past twelve months.

Appears in 2 contracts

Sources: Underwriting Agreement (AtriCure, Inc.), Underwriting Agreement (AtriCure, Inc.)

Audit Committee. The Board board of directors of the Company has validly appointed an audit committee whose composition satisfies the requirements of Rule 5605 of the Nasdaq Stock Market and the Board of Directors and/or the audit committee has adopted a charter that satisfies the requirements of Rule 5605 of the Nasdaq Stock Market. The audit committee has reviewed the adequacy of its charter within the past twelve months.

Appears in 1 contract

Sources: Underwriting Agreement (aTYR PHARMA INC)

Audit Committee. The Company’s Board of Directors has validly appointed an audit committee whose composition satisfies the requirements of Rule 5605 of the Nasdaq Stock Market and the Board of Directors and/or the audit committee has adopted a charter that satisfies the requirements of Rule 5605 of the Nasdaq Stock Market. The audit committee has reviewed the adequacy of its charter within the past twelve months.

Appears in 1 contract

Sources: Underwriting Agreement (Miragen Therapeutics, Inc.)

Audit Committee. The Company Board has validly appointed an audit committee whose composition satisfies the requirements of Rule 5605 4350(d)(2) of the Nasdaq Stock Market Rules of the NASDAQ (the “NASDAQ Rules”) and the Company Board and/or the such audit committee has adopted a charter that satisfies the requirements of Rule 5605 4350(d)(1) of the Nasdaq Stock MarketNASDAQ Rules. The Such audit committee has reviewed the adequacy of its charter within the past twelve 12 months.

Appears in 1 contract

Sources: Securities Purchase Agreement (MiddleBrook Pharmaceuticals, Inc.)